Entry Instance

HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "id": 829131,
    "url": "https://info.mzalendo.com/api/v0.1/hansard/entries/829131/?format=api",
    "text_counter": 200,
    "type": "speech",
    "speaker_name": "Murang’a CWR, JP",
    "speaker_title": "Hon. (Ms.) Sabina Chege",
    "speaker": {
        "id": 884,
        "legal_name": "Sabina Wanjiru Chege",
        "slug": "sabina-wanjiru-chege"
    },
    "content": "“pharmaceutical practitioner” means a person lawfully carrying on the practice of pharmacy; “pharmaceutical product” means any material or product intended for human or veterinary use presented in its finished dosage or form, that is subject to control by or under this Act; “pharmaceutical technologist” means a holder of a diploma in pharmacy from a training institution recognised by the Board; “pharmacist” means a holder of a degree in pharmacy from a training institution recognised by the Board; “pharmacovigilance” means the practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse reactions, and includes the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug related problem; “post market surveillance” means the practice of monitoring the safety and quality of a pharmaceutical drug or medical device after it has been released on the market and is an important part of the science of The electronic version of the Official Hansard Report is for information purposes only. Acertified version of this Report can be obtained from the Hansard Editor."
}